| Autoimmune kidney disease and impaired engulfment of apoptotic cells in mice with macrophage peroxisome proliferator-activated receptor γ or retinoid X receptor α deficiency T Rőszer, MP Menéndez-Gutiérrez, MI Lefterova, D Alameda, V Núñez, ... The Journal of Immunology 186 (1), 621-631, 2011 | 192 | 2011 |
| Retinoid X receptor α controls innate inflammatory responses through the up-regulation of chemokine expression V Núñez, D Alameda, D Rico, R Mota, P Gonzalo, M Cedenilla, T Fischer, ... Proceedings of the National Academy of Sciences 107 (23), 10626-10631, 2010 | 145 | 2010 |
| Deep MRD profiling defines outcome and unveils different modes of treatment resistance in standard-and high-risk myeloma I Goicoechea, N Puig, MT Cedena, L Burgos, L Cordón, MB Vidriales, ... Blood, The Journal of the American Society of Hematology 137 (1), 49-60, 2021 | 96 | 2021 |
| Immunogenomic identification and characterization of granulocytic myeloid-derived suppressor cells in multiple myeloma C Perez, C Botta, A Zabaleta, N Puig, MT Cedena, I Goicoechea, ... Blood, The Journal of the American Society of Hematology 136 (2), 199-209, 2020 | 90 | 2020 |
| YES1 drives lung cancer growth and progression and predicts sensitivity to dasatinib I Garmendia, MJ Pajares, F Hermida-Prado, D Ajona, C Bértolo, C Sainz, ... American journal of respiratory and critical care medicine 200 (7), 888-899, 2019 | 61 | 2019 |
| Functional and transcriptomic analysis of extracellular vesicles identifies calprotectin as a new prognostic marker in peripheral arterial disease (PAD) G Saenz-Pipaon, P San Martín, N Planell, A Maillo, S Ravassa, ... Journal of extracellular vesicles 9 (1), 1729646, 2020 | 43 | 2020 |
| Genome-wide profiling of non-smoking-related lung cancer cells reveals common RB1 rearrangements associated with histopathologic transformation in EGFR-mutant tumors E Pros, M Saigi, D Alameda, G Gomez-Mariano, B Martinez-Delgado, ... Annals of Oncology 31 (2), 274-282, 2020 | 35 | 2020 |
| Tumor cells in light-chain amyloidosis and myeloma show distinct transcriptional rewiring of normal plasma cell development D Alameda, I Goicoechea, M Vicari, E Arriazu, A Nevone, S Rodriguez, ... Blood, The Journal of the American Society of Hematology 138 (17), 1583-1589, 2021 | 18 | 2021 |
| Characterization of freshly isolated bone marrow mesenchymal stromal cells from healthy donors and patients with multiple myeloma: Transcriptional modulation of the … D Alameda, B Saez, D Lara-Astiaso, S Sarvide, M Lasa, D Alignani, ... Haematologica 105 (9), e470, 2020 | 15 | 2020 |
| Presence of somatic/germline homologous recombination repair (HRR) mutations and outcomes in metastatic castration-resistant prostate cancer (mCRPC) patients (pts) receiving … D Olmos, D Lorente, D Alameda, C Cattrini, N Romero-Laorden, ... Journal of Clinical Oncology 41 (16_suppl), 5003-5003, 2023 | 12 | 2023 |
| Immunogenetic characterization of clonal plasma cells in systemic light-chain amyloidosis I Cuenca, D Alameda, B Sanchez-Vega, D Gomez-Sanchez, D Alignani, ... Leukemia 35 (1), 245-249, 2021 | 12 | 2021 |
| Characterization of freshly isolated mesenchymal stromal cells from healthy and multiple myeloma bone marrow: transcriptional modulation of the microenvironment D Alameda, B Saez, D Lara-Astiaso, S Sarvide, M Lasa, D Alignani, ... Haematologica 105 (9), 235135, 2020 | 7 | 2020 |
| Impact of concurrent tumour events on the prostate cancer outcomes of germline BRCA2 mutation carriers R Lozano, E Castro, F Lopez-Campos, H Thorne, M Ramirez-Backhaus, ... European Journal of Cancer 185, 105-118, 2023 | 3 | 2023 |
| Understanding the Cellular Origin and Pathogenic Transcriptional Programs in Multiple Myeloma (MM) and Light-Chain Amyloidosis (AL) through the Dissection of the Normal Plasma … D Alameda, M Vicari, D Lara-Astiaso, M Lasa, N Puig, ... Blood, The Journal of the American Society of Hematology 132 (Supplement 1 …, 2018 | 2 | 2018 |
| Waldenström's Macroglobulinemia (WM) Is Preceded By Clonal Lymphopoiesis Including MYD88 L265P in Progenitor B Cells S Rodríguez, C Botta, J Celay, I Goicoechea, MJ Garcia-Barchino, ... Blood 134, 1527, 2019 | 1 | 2019 |
| Abstract LB-117: Dasatinib for the treatment of patients with non-small cell lung cancer harboring YES1 amplification I Garmendia, J Agorreta, MJ Pajares, D Ajona, D Alameda, C Behrens, ... Cancer Research 77 (13_Supplement), LB-117-LB-117, 2017 | 1 | 2017 |
| Treatment patterns and outcomes in metastatic castration-resistant prostate cancer patients with and without somatic or germline alterations in homologous recombination repair … D Olmos, D Lorente, D Alameda, C Cattrini, N Romero-Laorden, ... Annals of Oncology, 2024 | | 2024 |
| Large-scale silane bead-based SARS-CoV-2 testing of a nursing home in Spain identifies a viral reservoir during lockdown period ND Weber, A Goñi-Salaverri, JA Rodríguez, JP Unfried, D Alameda, ... medRxiv, 2021.02. 08.21251358, 2021 | | 2021 |
| Correlation between genomic alterations and germline mutations in men with metastatic castration-resistant prostate cancer (mCRPC) C Llacer Perez, L Oliva Fernandez, Canada-Higueras, E., MI Saez, ... ANNALS OF ONCOLOGY 32, S641-S642, 2021 | | 2021 |
| EXPLORING THE CELL OF ORIGIN AND THE PATHOLOGICAL TRANSCRIPTIONAL PROGRAMS IN MULTIPLE MYELOMA (MM) AND LIGHT CHAIN AMYLOIDOSIS (AL) BY DISSECTING THE DEVELOPMENT OF NORMAL … D Alameda, N Puig, MT Cedena, EM Ocio, R Lecumberri, J Labrador, ... HAEMATOLOGICA 104, 12-12, 2019 | | 2019 |
